Black Rock Inc. Rocket Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,192,627 shares of RCKT stock, worth $62.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,192,627
Previous 5,929,910
4.43%
Holding current value
$62.7 Million
Previous $160 Million
16.54%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RCKT
# of Institutions
231Shares Held
98.4MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$179 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA14MShares$142 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$66.6 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.71MShares$47.7 Million0.27% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.12MShares$41.7 Million1.58% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $766M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...